Xylo Technologies Ltd. (XYLO)
NASDAQ: XYLO · IEX Real-Time Price · USD
1.520
-0.110 (-6.75%)
May 3, 2024, 3:59 PM EDT - Market closed

Company Description

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally.

The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments.

It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease.

The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities.

In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform.

Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies.

The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024.

Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Xylo Technologies Ltd.
Xylo Technologies logo
Country Israel
Founded 1999
Industry Medical Devices
Sector Healthcare
Employees 84
CEO Liron Carmel

Contact Details

Address:
10 Hanechoshet Street
Tel Aviv, L3 6971072
Israel
Phone 972-3-6899124

Stock Details

Ticker Symbol XYLO
Exchange NASDAQ
Fiscal Year January - December
CIK Code 0001618500
ISIN Number US58471G4091
SIC Code 7374

Latest SEC Filings

Date Type Title
Apr 22, 2024 6-K Report of foreign issuer
Apr 22, 2024 20-F Annual and transition report of foreign private issuers
Apr 15, 2024 6-K Report of foreign issuer
Apr 15, 2024 424B3 Prospectus
Apr 9, 2024 6-K Report of foreign issuer
Mar 27, 2024 6-K Report of foreign issuer
Mar 19, 2024 6-K Report of foreign issuer
Mar 7, 2024 6-K Report of foreign issuer
Feb 22, 2024 6-K Report of foreign issuer
Feb 12, 2024 6-K Report of foreign issuer